Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30464896 | 1.00 | LMNA (0.53) | LMNAL3MBTL1KDM4EALDH1A1TDP1 | |
| SCHEMBL27948943 | 0.95 | LMNA (0.53) | LMNAL3MBTL1KDM4EALDH1A1TDP1 | |
| SCHEMBL28980175 | 0.94 | ALOX15 (0.52) | LMNAL3MBTL1ALDH1A1 | |
| SCHEMBL30464895 | 0.93 | LMNA (0.56) | LMNAL3MBTL1KDM4EALDH1A1TDP1 | |
| SCHEMBL18256026 | 0.93 | LMNA (0.56) | LMNAL3MBTL1KDM4EALDH1A1TDP1 | |
| SCHEMBL17073977 | 0.93 | ALOX15 (0.51) | LMNAL3MBTL1ALDH1A1 | |
| SCHEMBL28080449 | 0.93 | ALOX15 (0.51) | LMNAL3MBTL1ALDH1A1 | |
| SCHEMBL15456833 | 0.93 | ALOX15 (0.51) | LMNAL3MBTL1ALDH1A1 | |
| SCHEMBL23707002 | 0.93 | LMNA (0.48) | LMNAL3MBTL1KDM4EALDH1A1TDP1 | |
| SCHEMBL249973 | 0.92 | ALDH1A1 (0.52) | LMNAL3MBTL1KDM4EALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230345932-A1 | MONOTERPENOID/PHENYLPROPANOID CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS SEED TREATMENTS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2023-11-02 | — | — | US | disclosed |
| US-20230345932-A1 | MONOTERPENOID/PHENYLPROPANOID CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS SEED TREATMENTS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2023-11-02 | — | — | US | disclosed |
| US-11696581-B2 | Monoterpenoid/phenylpropanoid-containing compounds and methods of their making and use as seed treatments | KITTRICH CORPORATION (US) | 2023-07-11 | — | — | US | disclosed |
| US-11696581-B2 | Monoterpenoid/phenylpropanoid-containing compounds and methods of their making and use as seed treatments | KITTRICH CORPORATION (US) | 2023-07-11 | — | — | US | disclosed |
| US-20230189802-A1 | MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS BAITS | KITTRICH CORPORATION | 2023-06-22 | — | — | US | disclosed |
| US-20230189802-A1 | MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS BAITS | KITTRICH CORPORATION | 2023-06-22 | — | — | US | disclosed |
| US-20210235693-A1 | MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS SEED TREATMENTS | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11696581-B2 | Monoterpenoid/phenylpropanoid-containing compounds and methods of their making and use as seed treatments | ALOX5, PTGES, ALOX15 | LMNA 1679/4885L3MBTL1 1183/4885KDM4E 1470/4885 |
| US-20230189802-A1 | MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS BAITS | CYP51A1, CYP4A22, ACHE | LMNA 2776/4885L3MBTL1 709/4885KDM4E 1496/4885 |
| US-20230345932-A1 | MONOTERPENOID/PHENYLPROPANOID CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS SEED TREATMENTS | PTGES, ALOX5, GSTO1 | LMNA 1656/4885L3MBTL1 1167/4885KDM4E 1594/4885 |
| US-20210235693-A1 | MONOTERPENOID/PHENYLPROPANOID-CONTAINING COMPOUNDS AND METHODS OF THEIR MAKING AND USE AS SEED TREATMENTS | ALOX5, PTGES, ALOX15 | LMNA 1679/4885L3MBTL1 1183/4885KDM4E 1470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.